President and Founder Mark Cox has over 25 years of experience helping clients throughout North America and Europe value technologies, and develop and introduce new medical products. His expertise includes due diligence management, technology transfer and licensing, IP valuation and strategy, and product cost analysis. Mark has led or contributed his expertise to more than 20 due diligence efforts, and his cost-analyses and opportunity identification efforts have saved clients as much as $10 million annually on a single product line.
Mark founded AlvaMed in 2003 to provide consultation services to medical device companies throughout the product lifecycle. Before founding AlvaMed, Mark spent 16 years as a consultant, most of which were with Arthur D. Little.
Mark holds a BE in Metallurgy and Materials Science from Imperial College, London, and an MS in Materials Engineering from MIT.
